Published in J Mol Biol on January 15, 1999
Directed evolution of polymerase function by compartmentalized self-replication. Proc Natl Acad Sci U S A (2001) 8.89
Tuning genetic control through promoter engineering. Proc Natl Acad Sci U S A (2005) 4.07
Protein tolerance to random amino acid change. Proc Natl Acad Sci U S A (2004) 3.07
Initial mutations direct alternative pathways of protein evolution. PLoS Genet (2011) 2.01
Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase. Genetics (2002) 1.95
Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc Natl Acad Sci U S A (2000) 1.80
Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently. Chem Soc Rev (2015) 1.74
A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci U S A (2001) 1.58
Chemical and biochemical strategies for the randomization of protein encoding DNA sequences: library construction methods for directed evolution. Nucleic Acids Res (2004) 1.46
Customized optimization of metabolic pathways by combinatorial transcriptional engineering. Nucleic Acids Res (2012) 1.41
Evolutionary history of a specialized p450 propane monooxygenase. J Mol Biol (2008) 1.40
Contribution of gene amplification to evolution of increased antibiotic resistance in Salmonella typhimurium. Genetics (2009) 1.25
Combining computational and experimental screening for rapid optimization of protein properties. Proc Natl Acad Sci U S A (2002) 1.19
Directed evolution of recombinase specificity by split gene reassembly. Nucleic Acids Res (2010) 1.19
De novo generation of prion strains. Nat Rev Microbiol (2011) 1.17
Bacterial cell surface display of an enzyme library for selective screening of improved cellulase variants. Appl Environ Microbiol (2000) 1.05
Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase. J Mol Biol (2008) 1.05
Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor. Antimicrob Agents Chemother (2003) 0.99
Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold. PLoS One (2012) 0.96
A combined in vitro/in vivo selection for polymerases with novel promoter specificities. BMC Biotechnol (2001) 0.92
SpeedyGenes: an improved gene synthesis method for the efficient production of error-corrected, synthetic protein libraries for directed evolution. Protein Eng Des Sel (2014) 0.90
Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution. Antibiotics (Basel) (2014) 0.90
Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories. PLoS Comput Biol (2011) 0.89
Protein evolution by codon-based random deletions. Nucleic Acids Res (2004) 0.88
In vitro selection of mutant HDM2 resistant to Nutlin inhibition. PLoS One (2013) 0.87
Exploiting genomic knowledge in optimising molecular breeding programmes: algorithms from evolutionary computing. PLoS One (2012) 0.84
Selection of bacteriophage lambda integrases with altered recombination specificity by in vitro compartmentalization. Nucleic Acids Res (2009) 0.83
Environmental changes bridge evolutionary valleys. Sci Adv (2016) 0.83
Heterologous gene expression in Thermus thermophilus: beta-galactosidase, dibenzothiophene monooxygenase, PNB carboxy esterase, 2-aminobiphenyl-2,3-diol dioxygenase, and chloramphenicol acetyl transferase. J Ind Microbiol Biotechnol (2004) 0.82
High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition. Protein Sci (2009) 0.81
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution. BMC Biotechnol (2007) 0.80
Structure-based design of combinatorial mutagenesis libraries. Protein Sci (2015) 0.80
Integrating terminal truncation and oligopeptide fusion for a novel protein engineering strategy to improve specific activity and catalytic efficiency: alkaline α-amylase as a case study. Appl Environ Microbiol (2013) 0.79
The genetic code constrains yet facilitates Darwinian evolution. Nucleic Acids Res (2013) 0.79
The intelligent design of evolution. Mol Syst Biol (2006) 0.78
In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity. Antimicrob Agents Chemother (2015) 0.78
Computationally mapping sequence space to understand evolutionary protein engineering. Biotechnol Prog (2007) 0.77
Integrated mimicry of B cell antibody mutagenesis using yeast homologous recombination. Mol Biotechnol (2011) 0.75
Improved catalytic efficiency, thermophilicity, anti-salt and detergent tolerance of keratinase KerSMD by partially truncation of PPC domain. Sci Rep (2016) 0.75
Some aspects of E. coli promoter evolution observed in a molecular evolution experiment. J Mol Evol (2006) 0.75
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol (1998) 3.05
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
Original and artificial antibodies. Nature (1992) 1.97
Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol (1995) 1.79
Hepatocytes and scatter factor. Nature (1990) 1.77
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta (1991) 1.53
Mutation and selection during the secondary response to 2-phenyloxazolone. Proc Natl Acad Sci U S A (1991) 1.35
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
Epithelial scatter factor and development of the chick embryonic axis. Development (1990) 1.28
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J (2001) 1.28
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development (1995) 1.25
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. Eur J Immunol (1992) 1.15
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat Struct Biol (1999) 1.14
Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. J Mol Biol (2007) 1.12
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol (1998) 1.10
Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev Genet (1996) 1.07
Patients' perception of public, voluntary and private dispensaries in rural areas of Tanzania. East Afr Med J (1996) 1.04
Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem (1995) 0.96
Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev Genet (1995) 0.92
Factors affecting epithelial interactions. Ciba Found Symp (1987) 0.90
Scatter factor and other regulators of cell mobility. Br Med Bull (1989) 0.87
Colony assays for antibody fragments expressed in bacteria. J Immunol Methods (1991) 0.87
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans (2006) 0.87
Universal cloning and direct sequencing of rearranged antibody V genes using C region primers, biotin-captured cDNA and one-side PCR. J Immunol Methods (1995) 0.85
Expression of a Cx43 deletion mutant in 3T3 A31 fibroblasts prevents PDGF-induced inhibition of cell communication and suppresses cell growth. Exp Cell Res (1999) 0.83
HGF/SF inhibits junctional communication. Exp Cell Res (1995) 0.81
Topography of apolipoprotein B in subcellular fractions of rabbit liver probed with a panel of monoclonal antibodies. J Lipid Res (1993) 0.80
Determination of the intracellular distribution and pool sizes of apolipoprotein B in rabbit liver. Biochem J (1992) 0.80
Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. FEBS Lett (1998) 0.80
Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest (1977) 0.79
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. Atherosclerosis (1977) 0.79
Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate. Lipids (1980) 0.79
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. Lipids (1980) 0.78
Down-regulation of scatter factor in MRC 5 fibroblasts by epithelial-derived cells. A model for scatter factor modulation. J Cell Sci (1992) 0.78
A sensitive RNase protection assay for the quantitation of the mRNAs for the LDL receptor and HMG-CoA reductase in human total RNA. Effects of treatments on cells in culture designed to up- and down-regulate expression of the LDL receptor. Atherosclerosis (1991) 0.78
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. Eur J Immunol (1992) 0.77
Transforming growth factor-beta 1 and interleukin-1 beta stimulate LDL receptor activity in Hep G2 cells. Atherosclerosis (1992) 0.77
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. Exp Mol Pathol (1983) 0.77
Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells. Eur J Immunol (1997) 0.77
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. Biochim Biophys Acta (1982) 0.76
Membrane-bound apolipoprotein B is exposed at the cytosolic surface of liver microsomes. FEBS Lett (1992) 0.76
Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody. Biochem J (1995) 0.75
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins. Exp Mol Pathol (1980) 0.75
Microcirculation and hemorheology in NIDDM patients. Angiology (1990) 0.75
The distribution of apolipoprotein B in endoplasmic reticulum and Golgi subfractions of rabbit liver. Biochem Soc Trans (1990) 0.75
Topography of apolipoprotein B in subcellular fractions from rabbit liver. Biochem Soc Trans (1993) 0.75
Capabilities of public, voluntary and private dispensaries in basic health service provision. World Health Forum (1996) 0.75
Porcine smooth muscle cell-conditioned medium stimulates LDL receptor activity in Hep G2 cells. J Cell Sci (1992) 0.75
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim Biophys Acta (1981) 0.75